Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123531142 | 12353114 | 2 | F | 20160229 | 20160712 | 20160510 | 20160722 | EXP | DE-ACTELION-A-NJ2016-132784 | ACTELION | 58.00 | YR | A | F | Y | 0.00000 | 20160723 | OT | DE | CO |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123531142 | 12353114 | 1 | PS | VENTAVIS | ILOPROST | 1 | Respiratory (inhalation) | 1 DF (5 MCG) 6/D | 21779 | 5 | UG | INHALATION VAPOUR, SOLUTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123531142 | 12353114 | 1 | Pulmonary arterial hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123531142 | 12353114 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123531142 | 12353114 | Dyspnoea | |
| 123531142 | 12353114 | Oedema peripheral | |
| 123531142 | 12353114 | Oxygen saturation decreased | |
| 123531142 | 12353114 | Respiratory disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123531142 | 12353114 | 1 | 20150630 | 0 |